CREATED BY ELEASYS LLC

Month: June 2020

Why does the antiviral treatment of AIDS patients lead to bone fractures?

TeachableMedicalNews article 06262020

Teachable moment in classrooms:

  1. cellular basis of life chapter – transcription
  2. skeletal system chapter – actions of osteoblasts and osteoclasts
  3. skeletal system chapter– osteoclast form from monocyte
  4. microbiology – reverse transcriptase of HIV
  5. microbiology – lifecycle of retroviruses like HIV

The news item:  A recent news article reminded us the bone fractures suffered by  AIDS (acquired immunodeficiency syndrome) patients as the result of the side effect of their treatment:

https://www.washingtonblade.com/2019/07/18/gilead-hit-with-more-lawsuits-over-harmful-side-effects-of-aids-drug/

While the report is about lawsuits against the maker of one antiviral drug, the article is a reminder of the substantial bone loss in treated AIDS patients.

So, Why Do I Care??  In the USA there are over 500,000 AIDS patients who receive antiviral treatment to manage the disease. Most of them are in the 20-40 age range, so their bone health will affect them for decades of their lives. In addition, this surprise side effect may become the motivation for new research into osteoporosis, and that knowledge may improve the living conditions of all patients with osteoporosis.

Plain English, Please!!! First, let’s talk about what is in that antiviral pill. One component stops the reproduction of the virus; this called a reverse transcriptase inhibitor, and chemically it is a nucleotide type of chemical.  The other component stops the release of new virus particles; that is called a protease inhibitor, and chemically it is a small organic molecule.  Neither of these components target bones, so bone loss is an unexpected side effect.

Could antibodies from plasma of recovered patients defeat the SARS-CoV-2 virus?

TeachableMedicalNews article 06042020

Teachable moment in classrooms:

  1. cell chapter – endocytosis and phagocytosis as transport through cell membranes
  2. blood chapter – white blood cell types and their functions
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – macrophages of alveoli
  5. lymphatic and immune system chapter – antibody structure
  6. lymphatic and immune system chapter – antibodies are made for specific targets

The news item:  Recently reports appeared where blood plasma taken from recovered patients are given to seriously ill COVID-19 patients:

Blood plasma appears safe for COVID-19 patients in early trial results

Researchers report promising results in early safety trials of convalescent plasma therapy, in which the blood of COVID-19 survivors is used to treat patients.

The article mentions that antibodies in the plasma are the active ingredient, and that 5000 patients were evaluated in this trial to determine the safety of such treatment.

So, Why Do I Care??  Have you been living under a rock in the last few months??? The coronavirus, SARS-CoV-2, responsible for the COVID-19 disease has so far infected over 6 million people, and caused over 377,000 deaths worldwide (on the date of this article). The virus attacks the respiratory system, specifically the alveoli, and may cause pneumonia and death by respiratory failure.  The antibodies from the recovered patients hold promise as a possible treatment to lower the lethality of the virus.

Powered by WordPress & Theme by Anders Norén